Market Closed -
Nasdaq
04:00:00 2024-05-13 pm EDT
5-day change
1st Jan Change
1.26
USD
-1.56%
-4.55%
-16.56%
OPKO Health, Inc. Provides Revenue Guidance for the Year 2022
August 04, 2022 at 04:30 pm EDT
OPKO Health, Inc. provided revenue guidance for the year 2022. The company expects overall revenue for 2022 to be between $950 million and $1 billion.
Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M
May. 07
MT
Transcript : OPKO Health, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07
OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 07
CI
Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets
Mar. 28
MT
Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
Mar. 20
CI
Opko Health Insider Bought Shares Worth $444,300, According to a Recent SEC Filing
Mar. 14
MT
Opko Health Insider Bought Shares Worth $463,750, According to a Recent SEC Filing
Mar. 13
MT
Opko Health Insider Bought Shares Worth $559,380, According to a Recent SEC Filing
Mar. 12
MT
Barrington Cuts Price Target on OPKO Health to $1.50 From $2, Maintains Outperform Rating
Feb. 28
MT
Transcript : OPKO Health, Inc., Q4 2023 Earnings Call, Feb 27, 2024
Feb. 27
Earnings Flash (OPK) OPKO HEALTH Reports Q4 Revenue $181.9M, vs. Street Est of $177.5M
Feb. 27
MT
OPKO Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Feb. 27
CI
Drugmakers deepen efforts to tap into booming market for obesity drugs
Feb. 27
RE
Opko Health Insider Bought Shares Worth $991,700, According to a Recent SEC Filing
Feb. 21
MT
HealthSnap, Inc. announced that it has received $24.999999 million in funding from a group of investors
Feb. 20
CI
OPKO Health, Inc. Announces the Cessation of Alexis Borisy as Member of the Board of Directors and Member of Compensation Committee of the Board
Feb. 09
CI
NextPlat Preparing to Launch Opko Health Store on Alibaba's Tmall Global Platform
Feb. 05
MT
Opko Health Insider Bought Shares Worth $488,650, According to a Recent SEC Filing
Jan. 19
MT
Opko Health Insider Bought Shares Worth $386,200, According to a Recent SEC Filing
Jan. 18
MT
Opko Health Insider Bought Shares Worth $954,300, According to a Recent SEC Filing
Jan. 16
MT
Opko Health Insider Bought Shares Worth $480,379, According to a Recent SEC Filing
Jan. 11
MT
Transcript : OPKO Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:45 PM
Jan. 10
OPKO Health Closes Private Offering of $230 Million Convertible Notes Due 2029
Jan. 09
MT
Opko Health Insider Bought Shares Worth $1,344,600, According to a Recent SEC Filing
Jan. 08
MT
Opko Health Insider Bought Shares Worth $514,093, According to a Recent SEC Filing
Jan. 05
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.
More about the company
Last Close Price
1.28
USD
Average target price
4.25
USD
Spread / Average Target
+232.03%
Consensus
1st Jan change
Capi.
-16.56% 892M -15.77% 8.49B +60.25% 4.08B -43.01% 2.42B -9.98% 2.42B -3.24% 2.33B -3.40% 2.01B -19.79% 1.53B -40.57% 1.26B +9.11% 1.07B
Medical & Diagnostic Laboratories
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
OPKO HEALTH, INC. 